Gain Therapeutics Insider Trades
NASDAQ: GANXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Gain Therapeutics insider activity
No Gain Therapeutics insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Mack Gene (CFO and Interim CEO) buying 14,400 shares at $1.01 on Aug 9, 2024. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put GANX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
GANX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 9, 2024 | Islam KhalidExecutive Chairman | Buy | 50,000 | $49.94K | Form 4 |
| Aug 9, 2024 | Mack GeneCFO and Interim CEO | Buy | 14,400 | $14.54K | Form 4 |
| Jul 1, 2024 | RICHMAN ERIC IDirector | Buy | 12,000 | $14.52K | Form 4 |
| Jul 1, 2024 | RICHMAN ERIC IDirector | Buy | 5,000 | $6.15K | Form 4 |
| Mar 28, 2024 | Riley Jeffrey ScottDirector | Buy | 30,000 | $115.77K | Form 4 |
| Mar 26, 2024 | Alder MatthiasChief Executive Officer | Tax withholding | 6,085 | $24.71K | Form 4 |
| Mar 26, 2024 | Alder MatthiasChief Executive Officer | Option exercise | 637 | — | Form 4 |
| Mar 26, 2024 | Alder MatthiasChief Executive Officer | Option exercise | 825 | — | Form 4 |
| Mar 26, 2024 | Alder MatthiasChief Executive Officer | Option exercise | 18,750 | — | Form 4 |
| Dec 21, 2023 | Alder MatthiasChief Executive Officer | Sale | 206 | $506.76 | Form 4 |
| Dec 20, 2023 | Alder MatthiasChief Executive Officer | Option exercise | 637 | — | Form 4 |
| Dec 7, 2023 | Alder MatthiasChief Executive Officer | Sale | 1,820 | $4.55K | Form 4 |
| Oct 1, 2023 | Alder MatthiasChief Executive Officer | Option exercise | 825 | — | Form 4 |
| Sep 20, 2023 | Alder MatthiasChief Executive Officer | Option exercise | 2,550 | — | Form 4 |
| Sep 20, 2023 | RICHMAN ERIC IDirector | Option exercise | 54,900 | — | Form 4 |
| Jul 1, 2023 | Alder MatthiasChief Executive Officer | Option exercise | 3,300 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4